Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:1368:111-139.
doi: 10.1007/978-981-16-8969-7_6.

Predicting the Disease Severity of Virus Infection

Affiliations

Predicting the Disease Severity of Virus Infection

Xin Qi et al. Adv Exp Med Biol. 2022.

Abstract

The COVID-19 pandemic has resulted in unprecedented burden on global health and economic systems, promoting worldwide efforts to understand, control, and fight the disease. Due to the wide spectrum of clinical severity, effective risk factors, biomarkers, and models for predicting disease severity and mortality in COVID-19 patients are urgently needed to provide guidance for clinical intervention and management. In this chapter, we first describe the infection features of different COVID-19 strains and the potential of clinical features, cytokine storm and biomarkers in predicting the severity of COVID-19 patients. We focus on how scoring systems, mathematical models and artificial intelligence (AI)-based models can promote the classification of COVID-19 severity at the population or individual level. Moreover, the development perspective of biomarkers and models for predicting the severity of COVID-19 is prospected. Therefore, this chapter highlights the clinical significance of biomarkers and models related to COVID-19 severity and provides important clues for improving the outcomes of COVID-19 patients, thereby facilitating timely disease assessment and precision medicine for individual COVID-19 patients.

Keywords: AI-based model; Biomarker; COVID-19 severity; Cytokine storm; Mathematical model; Risk factor; Scoring system.

PubMed Disclaimer

Similar articles

References

    1. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242 - PubMed - DOI
    1. Arabi YM, Murthy S, Webb S (2020) COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med 46(5):833–836 - PubMed - DOI
    1. Yang Y et al (2020) Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol 146(1):119–127. e4. - PubMed - PMC - DOI
    1. Broman N et al (2021) IL-6 and other biomarkers as predictors of severity in COVID-19. Ann Med 53(1):410–412 - PubMed - PMC - DOI
    1. Overmyer KA et al (2021) Large-scale multi-omic analysis of COVID-19 severity. Cell Syst 12(1):23–40 e7 - PubMed - DOI

LinkOut - more resources